During my training I pursued my interest in solid tumor oncology and completed several research projects in breast medical oncology, with a specific interest in clinical outcomes in geriatric patients. Although a large number of older adults are diagnosed with breast cancer, these patients are often unfortunately excluded from clinical trials and more research is needed to better understand clinical outcomes and toxicities of novel therapeutics in this population. During my training, I completed a project which examined progression free survival and toxicities of CDK inhibitors in a geriatric population.